Addus HomeCare (NASDAQ:ADUS) EVP Brian Poff Sells 6,644 Shares of Company Stock

Key Points

• EVP Brian Poff sold 6,644 Addus HomeCare shares at an average price of $124.72, receiving about $828,640. He retained 57,048 shares after the sale, a 10.43% reduction in his position.
• Addus reported quarterly EPS of $1.83, beating the $1.79 consensus estimate; revenue rose 7% year over year to $387.74 million, slightly below expectations.
• Analysts’ consensus rating was Moderate Buy, with an average price target of $134.70. Institutional investors and hedge funds held 95.35% of the company’s shares.

Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) EVP Brian Poff sold 6,644 shares of Addus HomeCare stock in a transaction dated Friday, November 6th. The stock was sold at an average price of $124.72, for a total value of $828,639.68. Following the sale, the executive vice president directly owned 57,048 shares of the company's stock, valued at $7,115,026.56. This trade represents a 10.43% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Addus HomeCare Stock Performance

NASDAQ ADUS traded up $3.87 during trading hours on Tuesday, reaching $126.29. The stock had a trading volume of 225,844 shares, compared to its average volume of 237,872. The stock has a fifty day moving average of $117.74 and a 200 day moving average of $106.95. The stock has a market cap of $2.36 billion, a P/E ratio of 21.05, a price-to-earnings-growth ratio of 1.82 and a beta of 0.75. Addus HomeCare Corporation has a 52-week low of $87.95 and a 52-week high of $131.59. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.69 and a current ratio of 1.64.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.79 by $0.04. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The company had revenue of $387.74 million for the quarter, compared to the consensus estimate of $388.72 million. During the same quarter in the prior year, the company earned $1.56 EPS. Addus HomeCare's quarterly revenue was up 7.0% on a year-over-year basis. Sell-side analysts predict that Addus HomeCare Corporation will post 6.34 earnings per share for the current year.

Institutional Investors Weigh In On Addus HomeCare

Institutional investors have recently modified their holdings of the business. BlackRock Inc. acquired a new stake in Addus HomeCare in the 2nd quarter valued at $344,153,000. Bank of America Corp DE purchased a new stake in Addus HomeCare in the 2nd quarter worth $35,527,000. TimesSquare Capital Management LLC acquired a new position in Addus HomeCare during the second quarter worth $31,502,000. Punch & Associates Investment Management Inc. purchased a new position in Addus HomeCare during the second quarter valued at $20,911,000. Finally, William Blair Investment Management LLC purchased a new position in Addus HomeCare during the second quarter valued at $17,703,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. Citigroup cut shares of Addus HomeCare from a "market outperform" rating to a "neutral" rating in a report on Monday, September 14th. UBS Group upped their price target on shares of Addus HomeCare from $145.00 to $160.00 and gave the company a "buy" rating in a report on Thursday, November 5th. Royal Bank Of Canada increased their price target on Addus HomeCare from $130.00 to $134.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 5th. TD Cowen lifted their price objective on Addus HomeCare from $131.00 to $145.00 and gave the company a "buy" rating in a research note on Thursday, November 5th. Finally, Barclays lifted their price objective on Addus HomeCare from $96.00 to $101.00 and gave the company an "underweight" rating in a research note on Wednesday, November 4th. Seven equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $134.70.

Addus HomeCare Company Profile

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.